Tenofovir Disoproxil Fumarate Intermediates
Still deciding? Get samples first, Contact US !
View similar products
Tag list
- Product description
-
Product name:Tenofovir Disoproxil Fumarate Intermediates
CAS No.:147127-20-6
Structure:
Appearance:White powdery solid
Content:≥ 99.0%
Packaging:Cardboard bucketTenofovir Disoproxil Fumarate Intermediates are key components in the drug synthesis process.
1. Chemical properties
Structural complexity
Tenofovir Disoproxil Fumarate Intermediates have a unique and complex chemical structure and are an important cornerstone for the construction of tenofovir disoproxil fumarate molecules. Its molecular structure contains specific functional groups and chemical bonds, and these structural features determine their activity and selectivity in subsequent reactions.
Stability
Under appropriate storage conditions, it has a certain chemical stability. However, in a specific reaction environment, it can react according to the expected chemical path. This balance between stability and reactivity is crucial for drug synthesis.
2. Role in drug synthesis
The key to the synthesis step
It is an indispensable link in the synthesis of tenofovir disoproxil fumarate. They participate in a series of chemical reactions, such as substitution reactions, condensation reactions, etc., and gradually build the framework of the target drug molecule.
Quality impact
The quality of the intermediate directly affects the quality of the final tenofovir disoproxil fumarate. High-purity intermediates help reduce the introduction of impurities, thereby improving the safety and effectiveness of drugs.
3. Application areas
Pharmaceutical industry
Mainly used in the production of drugs for diseases such as AIDS and hepatitis B. Tenofovir disoproxil fumarate is an important drug ingredient for the treatment of these diseases, and the stable supply and high quality of intermediates ensure the large-scale production of related drugs.
Pharmaceutical research and development
In the process of new drug research and development, Tenofovir Disoproxil Fumarate Intermediates also provide basic materials for researchers to explore new dosage forms and new ways of administration of drugs, which helps to promote the continuous development of pharmaceutical science.
ABOUT FUERTAI
Building A Pharmaceutical Enterprise That Meets International Standards
Huangshi Fuertal Pharmaceutical Technology Co., Ltd. was established on July 19, 2013, located in the Biomedical Park of Xisaishan Industrial Park in Huangshi City. It covers an area of 56000 square meters, has a registered capital of 30 million yuan, a total investment of 150 million yuan, and a designed annual production capacity of 6500 tons. The company is mainly engaged in the research and development, production, and sales of antiviral drug Tenofovir and related intermediates. The company currently has 150 employees, including 22 full-time staff in the technology research and development center, and employs 4 technical consultants with doctoral and master's degrees.
Keyword:
Tenofovir Disoproxil Fumarate Intermediates
Still deciding? Get samples first, Contact US !
Products Category
Share to
Inquire Now
We will contact you within one working day. Please pay attention to your email.